Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $5.04 Million - $5.68 Million
19,700 New
19,700 $5.67 Million
Q2 2023

Aug 14, 2023

BUY
$214.27 - $253.37 $7.03 Million - $8.31 Million
32,800 New
32,800 $7.28 Million
Q4 2022

Feb 14, 2023

BUY
$229.03 - $291.01 $9.69 Million - $12.3 Million
42,300 New
42,300 $11.1 Million
Q4 2019

Feb 14, 2020

BUY
$189.21 - $243.2 $3.99 Million - $5.13 Million
21,100 Added 208.91%
31,200 $7.52 Million
Q3 2019

Nov 14, 2019

SELL
$174.11 - $208.62 $2 Million - $2.4 Million
-11,500 Reduced 53.24%
10,100 $1.95 Million
Q1 2018

May 15, 2018

SELL
$169.43 - $198.0 $4.83 Million - $5.64 Million
-28,500 Reduced 56.89%
21,600 $3.68 Million
Q4 2017

Feb 14, 2018

BUY
$168.79 - $188.59 $67,516 - $75,436
400 Added 0.8%
50,100 $8.71 Million
Q3 2017

Nov 14, 2017

BUY
$167.29 - $191.0 $8.31 Million - $9.49 Million
49,700
49,700 $9.27 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.